Human coronavirus 229E (HCoV-229E)

Human coronavirus 229E (HCoV-229E) is a species of RNA virus in the genus Alphacoronavirus that primarily infects humans, causing the common cold and occasionally severe lower respiratory tract infections in immunocompromised individuals (Source: NIH, PubMed). While HCoV-229E itself is a whole virus rather than a single molecular target, it contains several key proteins that serve as therapeutic targets, including the Spike (S) protein for entry, the Main Protease (Mpro) for polyprotein processing, and the RNA-dependent RNA polymerase (RdRp) for genome replication (Source: UniProt, PMC7250777). The virus utilizes the human Aminopeptidase N (CD13) receptor to enter host cells, a process that can be inhibited by specific entry blockers (Source: Nature Communications). Research into HCoV-229E often serves as a model for studying broader coronavirus biology and developing pan-coronavirus antivirals. Drugs like Remdesivir have shown in vitro activity against HCoV-229E by targeting its replication machinery (Source: PubChem).

Other names

Human coronavirus 229E (HCoV-229E)HCoV-229E virus

Antiviral agents targeting HCoV-229E typically act by inhibiting viral RNA-dependent RNA polymerase (e.g., Remdesivir), blocking viral entry by inhibiting host proteases like TMPRSS2 (e.g., Camostat), or interfering with endosomal acidification (e.g., Chloroquine).